Proxy Votes Now

Home › Funds › American Century › Avantis U.S. Small Cap Equity ETF

Avantis U.S. Small Cap Equity ETF (AVSC) proxy voting record 2025-2026

Fund family: American Century · Filed by AMERICAN CENTURY ETF TRUST (CIK 1710607) · SEC series S000074835

Ticker: AVSC (C000233056)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 12,104 with, 50 against, 0 abstentions (not counted as with management); 3 items carried no recommendation. Shareholder proposals: 27 FOR, 17 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with American Century as a whole

The same two figures as American Century’s manager page (564,755 ballot items across 76 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsAmerican CenturyItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)83.4%11,75188.0%451,178
Backed environmental and social shareholder proposals at US companiesn/a72.0%2,319

Where this fund voted differently from most American Century funds

Each ballot item this fund voted is set against the votes of the other American Century funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most American Century funds on 3 items (0.1% of the 9,202 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost American Century fundsMgmtResult
Duolingo, Inc.2026-06-03To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers.AgainstFOR — 5 of 6 American Century fundsAgainstPassed (calculated), 99.3% support
Akero Therapeutics, Inc.2025-12-02To approve, on an advisory, non-binding basis, the payment of certain compensation that may be paid or become payable by Akero to its named executive officers in connection with the Merger.AgainstFOR — 5 of 6 American Century fundsAgainstApproved, 98.0% support
Veeco Instruments Inc.2026-02-06To approve, on a non-binding, advisory basis, the compensation that will be paid or become payable to the named executive officers of Veeco that is based on or otherwise relates to the transactions contemplated by the Merger Agreement; andAgainstFOR — 6 of 9 American Century fundsAgainstApproved, 98.9% support

Download all 3 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 90.7% of this fund’s 12,154 such votes could be given a sector; the other 1,130 (9.3%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Finance2,72830.1%
Consumer Discretionary2,540291.1%
Health Care1,549100.6%
Industrials1,48020.1%
Technology1,06220.2%
Energy60600.0%
Consumer Staples28941.4%
Utilities24500.0%
Telecommunications17400.0%
Basic Materials15100.0%
Miscellaneous11200.0%
Real Estate8800.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections8,29723
Say-on-Pay1,4490
Audit-related1,3990
Compensation4980
Corporate Governance32514
Extraordinary Transactions1522
Capital Structure1413
Shareholder Rights and Defenses431
Environment or Climate44
Other Social Issues31

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Victoria's Secret & Co.June 11, 2026$16M110
ViaSat, Inc.September 4, 2025$14M60
Viavi Solutions Inc.November 12, 2025$14M130
Marqeta, Inc.June 10, 2026$13M80
10x Genomics, Inc.June 4, 2026$12M50
The Cheesecake Factory IncorporatedMay 28, 2026$12M100
Ligand Pharmaceuticals IncorporatedJune 5, 2026$11M110
FormFactor, Inc.May 15, 2026$11M110

Notable votes against management

MeetingCompanyProposalFundMgmt
April 22, 2026Dana IncorporatedShareholder proposal to require an independent Board Chairman. Shareholder proposalAgainstFor
April 24, 2026ArcBest CorporationA shareholder proposal to approve GHG emissions reduction targets, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
May 13, 2026ICU Medical, Inc.To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. Shareholder proposalAgainstFor
April 15, 2026Sonoco Products CompanyAdvisory (non-binding) shareholder proposal - avoid brand damage from political spending. Shareholder proposalAgainstFor
May 21, 2026Meritage Homes CorporationShareholder proposal to improve shareholder ability to call for a special shareholder meeting. Shareholder proposalAgainstFor
May 7, 2026Wolverine World Wide, Inc.Shareholder proposal regarding new climate change polices or practices. Shareholder proposalAgainstFor
May 21, 2026Harley-Davidson, Inc.To vote on a shareholder proposal regarding a climate transition plan. Shareholder proposalAgainstFor
July 11, 2025Brookdale Senior Living Inc.Election of eight (8) nominees to serve as directors to the Board for a one-year term ending at the Company's next annual meeting of stockholders and until his or her successor has been duly elected and qualified. COMPANY NOMINEES OPPOSED BY ORTELIUS: Jordan R. AsherForAgainst
July 11, 2025Brookdale Senior Living Inc.Election of eight (8) nominees to serve as directors to the Board for a one-year term ending at the Company's next annual meeting of stockholders and until his or her successor has been duly elected and qualified. COMPANY NOMINEES OPPOSED BY ORTELIUS: Claudia N. DraytonForAgainst
June 16, 2026PENN Entertainment, Inc.Advisory vote on a shareholder proposal regarding the annual election of directors, if properly presented. Shareholder proposalForAgainst
May 1, 2026AMN Healthcare Services, Inc.A shareholder proposal entitled: "Independent Board Chairman." Shareholder proposalAgainstFor
May 4, 2026Asbury Automotive Group, Inc.Stockholder proposal regarding special stockholder meetings. Shareholder proposalForAgainst

Contested meetings

Meetings with a proxy contest or competing nominees (13 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

12,314 ballot items at 1,538 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Avantis U.S. Small Cap Equity ETF (AVSC) voted at 1,538 shareholder meetings of 1,471 companies, on 12,314 ballot items in all. Where management made a recommendation, the fund followed it on 99.6% of the items and voted against it 50 times. Its most frequent area of disagreement was director elections (23 of its votes against management). It voted on 51 shareholder proposals. It voted FOR the board's own proposals less often than American Century's funds as a whole (83.4% against 88.0%). It voted differently from most American Century funds on 3 items. 13 of its meetings were contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of American Century’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.